Low dose aspirin use is becoming almost ubiquitous in cardiovascular risk modification, cancer risk modification, and in other areas whether appropriately indicated…or not.
Bobby Lazzara, MD
A study that compared motor and nonmotor outcomes of DBS for Parkinson disease may show promise for patients' quality of life.
A new study with longitudinal follow-up looked at disability trajectories after stroke compared with myocardial infarction.
A study of over 80,000 patients confirmed another strong reason to prevent young people from repetitive head blows.
In this video, Dr. Lazzara discusses a new study that identified patients at greatest risk of memory loss and global loss of cognitive function.
A meta-analysis compared medical therapy with medical therapy plus angioplasty for the treatment of symptomatic vertebral artery stenosis.
An abstract presented at ACC 2017 explored the cardiovascular effects of cannabis use.
Patients with Parkinson disease experiencing “off” episodes on levodopa/carbidopa now have another treatment option.
Is selective serotonin reuptake inhibitor use associated with an increased risk of spontaneous intracranial hemorrhage?
Is the parkinsonian phenotype seen in welders related to the exposure of manganese-containing welding fumes?